In non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and pancreatic ductal adenocarcinoma (PDAC), FSP1 is expressed at higher levels in KRAS mutant tumor cells compared to normal cells [25]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.